Similar articles

• Balancing the benefits and harms of low-dose computed tomography screening for lung cancer: Medicare's options for coverage.

  Wiener RS. Wiener RS. Ann Intern Med. 2014 Sep 16;161(6):445-6. doi: 10.7326/M14-1352. Ann Intern Med. 2014. PMID: 24957566 No abstract available.
• The importance of lung cancer screening with low-dose computed tomography for Medicare beneficiaries.

  Wood DE. Wood DE. JAMA Intern Med. 2014 Dec;174(12):2016-8. doi: 10.1001/jamainternmed.2014.5623. JAMA Intern Med. 2014. PMID: 25317992
• Lung Cancer Screening Comes of Age.

  Worley S. Worley S. Manag Care. 2015 Apr;24(4):36-9. Manag Care. 2015. PMID: 26489175 No abstract available.
• Low-Dose Computed Tomography for Lung Cancer Screening: The Protocol and The Dose.

  McDermott S, Kalra MK. McDermott S, et al. Semin Roentgenol. 2017 Jul;52(3):132-136. doi: 10.1053/j.ro.2017.06.002. Epub 2017 Jun 3. Semin Roentgenol. 2017. PMID: 28734394 Review. No abstract available.
• Lung cancer screening with low-dose computed tomography: an analysis of the MEDCAC decision.

  Parker MS, Groves RC, Fowler AA 3rd, Shepherd RW, Cassano AD, Cafaro PL, Chestnut GT. Parker MS, et al. J Thorac Imaging. 2015 Jan;30(1):15-23. doi: 10.1097/RTI.0000000000000119. J Thorac Imaging. 2015. PMID: 25286290 Review.